Codiak BioSciences, Inc. Deferred Tax Assets, Deferred Income
Codiak BioSciences, Inc. had Deferred Tax Assets, Deferred Income of $11.92 million as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2022-03-10
- 2021-12-31: Deferred Tax Assets, Deferred Income $11.92M.
- 2020-12-31: Deferred Tax Assets, Deferred Income $17.12M.
- 2019-12-31: Deferred Tax Assets, Deferred Income $15.19M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2021-12-31 | $11.92M 10-K · filed 2022-03-10 |
| 2020-12-31 | $17.12M 10-K · filed 2022-03-10 |
| 2019-12-31 | $15.19M 10-K · filed 2021-03-17 |